Product category:
Reagents and catalysts
News Release from: Randox Laboratories | Subject: Adhesion molecule biochip arrays
Edited by the Laboratorytalk Editorial
Team on 03 December 2007
Multi-analyte adhesion molecule testing
Adhesion molecule biochip arrays from Randox allow simultaneous detection of up to five adhesion molecules in a single undivided patient sample - ideal for a multitude of research purposes
Adhesion molecules are proteins capable of binding to other molecules on the surface of an adjacent cell or part of the extracellular matrix They play a key role in development and immune processes for example, in the functions of leukocytes, where they mediate contact with blood vessels endothelia
This article was originally published on Laboratorytalk on 12 Aug 2005 at 8.00am (UK)
Related stories
Biochip technology comes to the routine lab
Latest innovation in multi-analyte biochip array technology is described as the perfect candidate for profiling drugs of abuse or cytokine arrays
Adhesion molecules can be found in the cell membrane or as soluble proteins in the blood.
Altered levels of these proteins have been found in pathological states including cardiovascular disease, stroke and cancer.
Biochip arrays utilise biochip array technology, which is based on Elisa principles of sandwich or competitive immunoassays.
The 9x9mm biochip acts as a reaction platform, with five adhesion molecule specific antibodies attached at pre-defined sites on the surface.
Up to five analytes can be measured simultaneously using just 25ml of patient sample and either human serum or plasma can be tested. Request a free brochure from Randox Laboratories ...
• Randox Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

